Verily
Verily is developing tools and platforms to enable more continuous health data collection for timely decision-making and effective interventions. They are running longitudinal studies to better understand ways to predict and prevent disease onset and progression.
4
Funding Rounds
$2.8b
Money raised
Overview
Verily is developing tools and platforms to enable more continuous health data collection for timely decision-making and effective interventions. They are running longitudinal studies to better understand ways to predict and prevent disease onset and progression.
| Name | Phone | Social networks | |
|---|---|---|---|
| An** Co**** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja*** Ku***** | - | - | linkedin twitter |
Funding
Funding series
Funding Series Analysis
The company Verily has raised a total of $1.82b in funding over 4 rounds.
Key Insights:
- Verily - Series Unknown, September 2022: $18m
- Verily , January 2019: $1b
- Verily Life Sciences , January 2017: $800m
- Verily funding round, January 2019: $1b
Verily - Series Unknown, September 2022
$18m
Verily , January 2019
$1b
Verily Life Sciences , January 2017
$800m
Verily funding round, January 2019
$1b
Industries
Verily is active in the following industries:
- Healthcare
- Diagnosis
- Electronic health record
- Diabetes management
- Software
- Biomedical engineering
- Hardware
- Cardiovascular disease
- Engineering
- Technology
- Biology
- Biotechnology
- Cardiology
- Internal medicine
- Digital health
- Medicine
- Diabetes mellitus
